Sort
17,828 grants matching “crispr”
Next-generation Drosophila cell lines to elucidate the cellular basis of human diseases
$671,292Norbert Perrimon · Harvard Medical School · R24 · FY2017 · OD
Regulation of DNA methylation by TETs and QSER1
$671,048Todd R Evans · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HD
Regulation of DNA methylation by TETs and QSER1
$671,048Todd R Evans · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HD
Mechanisms and targeting of aberrant Gas activation in myeloid neoplasms
$670,945Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC
$670,936Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
Identifying and characterizing functional noncoding mutations in multiple myeloma
$670,724Benjamin Tycko · Hackensack University Medical Center · R01 · FY2024 · CA
Sex Hormone Receptor Component And The Cell Genome
$670,709Bert W O'Malley · Baylor College Of Medicine · R01 · FY2023 · HD
Sex Hormone Receptor Component And The Cell Genome
$670,709David M Lonard · Baylor College Of Medicine · R01 · FY2025 · HD
In vivo delivery of engineered tRNAs for suppression of nonsense mutations
$670,446John D. Lueck · University Of Rochester · R01 · FY2024 · HL
Novel components of mitochondrial regulation of insulin secretion in type 2 diabetes
$670,313Akos A Gerencser · Buck Institute For Research On Aging · R01 · FY2024 · DK
Novel components of mitochondrial regulation of insulin secretion in type 2 diabetes
$670,313Akos A Gerencser · Buck Institute For Research On Aging · R01 · FY2025 · DK
Development of CD46 theranostics for imaging and treatment of multiple myeloma
$670,219Robert Richard Flavell · University Of California, San Francisco · R01 · FY2025 · CA
Development of CD46 theranostics for imaging and treatment of multiple myeloma
$670,212Robert Richard Flavell · University Of California, San Francisco · R01 · FY2022 · CA
Molecular Mediators of Cell-free DNA biogenesis
$670,147Ben H Park · Vanderbilt University Medical Center · R01 · FY2025 · CA
Modeling and Characterization of NAFLD Phenotypes in a Severely Affected Family
$669,949Aras Nikodemas Mattis · University Of California, San Francisco · R01 · FY2024 · DK
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy
$669,679Joseph C Wu · Stanford University · R01 · FY2022 · HL
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy
$669,679Joseph C Wu · Stanford University · R01 · FY2021 · HL
Novel CRISPR-Cas9 protein delivery to T cells in vivo by targeting CD7
$669,671Guohua Yi · University Of Texas Hlth Ctr At Tyler · UG3 · FY2021 · AI
Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies
$669,664Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Regulation of Hemoglobin Switching
$669,586Gerd A Blobel · Children'S Hosp Of Philadelphia · R01 · FY2024 · HL
Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia
$669,389Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
Mechanism of protein quality control at the endoplasmic reticulum
$669,370Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Orthogonal CRISPR GEMMs
$669,338Michael T McManus · University Of California, San Francisco · R01 · FY2025 · CA
Proinflammatory B Cells Defined by TIM-4 in the Alloimmune Response
$669,277David M Rothstein · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Functional and translational studies of RUNX1 and CBFB in hematopoiesis
$669,266Paul Liu · National Human Genome Research Institute · ZIA · FY2016 · HG